VERALOX THERAPEUTICS

veralox-therapeutics-logo

Veralox Therapeutics develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type one diabetes. Based on an understanding of the molecular mechanisms of these diseases, these efforts will lead to new treatment paradigms and better outcomes for patients.

#SimilarOrganizations #People #Financial #Event #Website #More

VERALOX THERAPEUTICS

Social Links:

Industry:
Biotechnology Medical Pharmaceutical Therapeutics

Founded:
2017-01-01

Address:
Frederick, Maryland, United States

Country:
United States

Website Url:
http://www.veralox.com

Total Employee:
1+

Status:
Active

Contact:
(301) 360-3502

Total Funding:
22 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon WordPress Nginx Sitelinks Search Box Microsoft Exchange Online Organization Schema


Similar Organizations

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

naegis-pharmaceuticals-logo

Naegis Pharmaceuticals

Naegis Pharmaceuticals is driven to discover new therapies that target underlying chronic inflammatory processes in eye diseases.

proteostasis-therapeutics-logo

Proteostasis Therapeutics

Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.

tiburio-therapeutics-logo

Tiburio Therapeutics

Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.


Current Advisors List

not_available_image

Jamie Stiff Board Member @ Veralox Therapeutics
Board_member

ben-scruggs_image

Ben Scruggs Board Member @ Veralox Therapeutics
Board_member

Current Employees Featured

jeffrey-w-strovel_image

Jeffrey W. Strovel
Jeffrey W. Strovel Co-Founder and Chief Executive Officer @ Veralox Therapeutics
Co-Founder and Chief Executive Officer
2018-04-01

matthew-b-boxer_image

Matthew B. Boxer
Matthew B. Boxer Co-Founder and Chief Operating Officer @ Veralox Therapeutics
Co-Founder and Chief Operating Officer
2017-12-01

david-j-maloney_image

David J. Maloney
David J. Maloney Co-Founder and Chief Scientific Officer @ Veralox Therapeutics
Co-Founder and Chief Scientific Officer
2017-12-01

lisa-beck_image

Lisa Beck
Lisa Beck Chief Business Officer @ Veralox Therapeutics
Chief Business Officer
2022-02-01

Founder


david-j-maloney_image

David J. Maloney

jeffrey-w-strovel_image

Jeffrey W. Strovel

matthew-b-boxer_image

Matthew B. Boxer

Investors List

maryland-technology-development-corporation_image

TEDCO

TEDCO investment in Series A - Veralox Therapeutics

university-system-of-maryland_image

(Momentum Fund) University System of Maryland

(Momentum Fund) University System of Maryland investment in Series A - Veralox Therapeutics

hatteras-venture-partners_image

Hatteras Venture Partners

Hatteras Venture Partners investment in Series A - Veralox Therapeutics

point-field-partners_image

Point Field Partners

Point Field Partners investment in Series A - Veralox Therapeutics

virginia-tech-carilion-vtc-innovation-fund_image

Virginia Tech Carilion (VTC) Innovation Fund

Virginia Tech Carilion (VTC) Innovation Fund investment in Series A - Veralox Therapeutics

alumni-ventures-group_image

Alumni Ventures

Alumni Ventures investment in Series A - Veralox Therapeutics

jdrf-t1d-fund_image

JDRF T1D Fund

JDRF T1D Fund investment in Series A - Veralox Therapeutics

genesys-capital_image

Genesys Capital

Genesys Capital investment in Series A - Veralox Therapeutics

alexandria-venture-investments_image

Alexandria Venture Investments

Alexandria Venture Investments investment in Series A - Veralox Therapeutics

sanofi-genzyme-bioventures_image

Sanofi Ventures

Sanofi Ventures investment in Series A - Veralox Therapeutics

Key Employee Changes

Date New article
2022-02-23 Veralox Therapeutics Appoints Lisa Beck as Chief Business Officer

Official Site Inspections

http://www.veralox.com

  • Host name: ec2-54-157-188-110.compute-1.amazonaws.com
  • IP address: 54.157.188.110
  • Location: Ashburn United States
  • Latitude: 39.0481
  • Longitude: -77.4728
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20149

Loading ...

More informations about "Veralox Therapeutics" on Search Engine